Louise A. Koopman is an accomplished professional in the field of translational research, currently serving as Associate Director at Genmab since September 2015, leading efforts in antibody drug candidate development for cancer therapies. Prior experience includes positions as Principal Scientist at Celgene Avilomics Research, leading preclinical research for novel small molecule inhibitors, and as Senior Research Scientist at Dana-Farber Cancer Institute, overseeing collaborative research on therapeutic compounds. Louise's background in oncology research extends to leadership roles at Biogen and foundational work in education as Founder and Board President of the First Dutch School in Boston. Educational qualifications include a Ph.D. in Cancer Biology from Leiden University and postdoctoral research at Harvard University.
This person is not in any teams
This person is not in any offices